Cholinergic Muscarinic Antagonist

This page covers all Cholinergic Muscarinic Antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M1, Potassium voltage-gated channel subfamily H member 2.

Targets

Muscarinic acetylcholine receptor M3 · Muscarinic acetylcholine receptor M1 · Potassium voltage-gated channel subfamily H member 2 · Muscarinic acetylcholine receptor M4

Marketed (7)

• Enablex · AbbVie · Urology
  Enablex works by blocking the action of a chemical called acetylcholine on the bladder muscle, which helps to relax the muscle and improve bladder control.
• Detrol · Upjohn · Metabolic
  Detrol works by blocking the action of a chemical called acetylcholine at the muscarinic receptors in the bladder muscle.
• Ditropan Xl · Hisamitsu Pharmaceutical Co., Inc. · Metabolic
  Oxybutynin works by blocking the action of a chemical called acetylcholine on the bladder muscle, reducing spasms and urgency.
• Vesicare · Astellas Pharma · Urology
  Vesicare works by blocking the action of a chemical called acetylcholine at the muscarinic receptors in the bladder muscle, reducing muscle contractions and urgency.
• Urispas · Pain
• Homatropin · Gastroenterology
• Sanctura · AbbVie · Urology
  Sanctura works by blocking the action of a chemical called acetylcholine at the M3 receptor in the bladder muscle, reducing muscle contractions and urgency.

Patent intelligence

• cholinergic muscarinic antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates